Report Overview
Lisinopril API (Active Pharmaceutical Ingredient) is a critical component in the production of Lisinoprilbased medications, which belong to the class of angiotensin-converting enzyme (ACE) inhibitors. These medications are widely used to manage hypertension, heart failure, and improve survival rates after heart attacks. The growing prevalence of cardiovascular diseases has led to increased demand for Lisinopril API in the global pharmaceutical market.
Market Analysis
In 2024, the global Lisinopril API Market was valued at approximately USD 680 million and is expected to reach USD 920 million by 2032, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032.
The United States market alone was valued at USD 220 million in 2024 and is projected to grow to USD 290 million by 2032, with a CAGR of 3.5% during the forecast period.
